These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 30992000)

  • 1. The impact of Medicare part D on income-related inequality in pharmaceutical expenditure.
    Carvalho N; Petrie D; Chen L; Salomon JA; Clarke P
    Int J Equity Health; 2019 Apr; 18(1):57. PubMed ID: 30992000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variation in Prescription Drug Coverage Enrollment Among Vulnerable Beneficiaries With Glaucoma Before and After the Implementation of Medicare Part D.
    Blumberg DM; Prager AJ; Liebmann JM
    JAMA Ophthalmol; 2016 Feb; 134(2):212-20. PubMed ID: 26720853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Medicare Part D on Prescription Drug Spending and Health Care Use: 6 Years of Follow-up, 2007-2012.
    Park T; Jung J
    J Manag Care Spec Pharm; 2017 Jan; 23(1):5-12. PubMed ID: 28025927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Per-Prescription Drug Expenditure by Source of Payment and Income Level in the United States, 1997 to 2015.
    Tang W; Xie J; Kong F; Malone DC
    Value Health; 2019 Aug; 22(8):871-877. PubMed ID: 31426927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescription drug coverage among elderly and disabled Americans: can Medicare-Part D reduce inequities in access?
    Kanavos P; Gemmill-Toyama M
    Int J Health Care Finance Econ; 2010 Sep; 10(3):203-18. PubMed ID: 20213234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Medicare Part D on drug affordability and use: Are seniors with prior high out-of-pocket drug spending affected more?
    Mott DA; Thorpe JM; Thorpe CT; Kreling DH; Gadkari AS
    Res Social Adm Pharm; 2010 Jun; 6(2):90-9. PubMed ID: 20511108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Closing the Medicare Doughnut Hole: Changes in Prescription Drug Utilization and Out-of-Pocket Spending Among Medicare Beneficiaries With Part D Coverage After the Affordable Care Act.
    Bonakdar Tehrani A; Cunningham PJ
    Med Care; 2017 Jan; 55(1):43-49. PubMed ID: 27547949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Medicare Part D on the Proportion of Out-of-Pocket Prescription Drug Costs Among Older Adults With Diabetes.
    Choi YJ; Jia H; Gross T; Weinger K; Stone PW; Smaldone AM
    Diabetes Care; 2017 Apr; 40(4):502-508. PubMed ID: 27803119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of Medicare Part D on health care utilization for non-elderly Medicare recipients with disabilities.
    Nelson RE; Nelson SL; Huttner B; Gundlapalli A
    Disabil Health J; 2014 Jan; 7(1):64-9. PubMed ID: 24411509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Proposed Medicare Part B to Part D Shift With Associated Changes in Total Spending and Patient Cost-Sharing for Prescription Drugs.
    Hwang TJ; Jain N; Lauffenburger JC; Vokinger KN; Kesselheim AS
    JAMA Intern Med; 2019 Mar; 179(3):374-380. PubMed ID: 30640379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Out-of-pocket health spending by poor and near-poor elderly Medicare beneficiaries.
    Gross DJ; Alecxih L; Gibson MJ; Corea J; Caplan C; Brangan N
    Health Serv Res; 1999 Apr; 34(1 Pt 2):241-54. PubMed ID: 10199672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantifying income-related inequality in healthcare delivery in the United States.
    Chen AY; Escarce JJ
    Med Care; 2004 Jan; 42(1):38-47. PubMed ID: 14713738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Medicare Part D for Medicare-age adults with arthritis: prescription use, prescription expenditures, and medical spending from 2005 to 2008.
    Cheng LI; Rascati KL
    Arthritis Care Res (Hoboken); 2012 Sep; 64(9):1423-9. PubMed ID: 22508663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prescription Drug Spending in Fee-for-Service Medicare, 2008-2019.
    Dusetzina SB; Huskamp HA; Qin X; Keating NL
    JAMA; 2022 Oct; 328(15):1515-1522. PubMed ID: 36255428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-year impact of Medicare Part D coverage gap reform on drug expenditures and utilization.
    Park J; Look KA
    Health Serv Res; 2022 Feb; 57(1):56-65. PubMed ID: 33870486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescription coverage, use and spending before and after Part D implementation: a national longitudinal panel study.
    Safran DG; Strollo MK; Guterman S; Li A; Rogers WH; Neuman P
    J Gen Intern Med; 2010 Jan; 25(1):10-7. PubMed ID: 19882193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicare part D after 2 years.
    Joyce GF; Goldman DP; Vogt WB; Sun E; Jena AB
    Am J Manag Care; 2009 Aug; 15(8):536-44. PubMed ID: 19670957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of Medicare Part D on drug and medical spending.
    Zhang Y; Donohue JM; Lave JR; O'Donnell G; Newhouse JP
    N Engl J Med; 2009 Jul; 361(1):52-61. PubMed ID: 19571283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of prescription drug expenditures and medication adherence among medicare part D beneficiaries with and without the low-income supplement.
    Yala SM; Duru OK; Ettner SL; Turk N; Mangione CM; Brown AF
    BMC Health Serv Res; 2014 Dec; 14():665. PubMed ID: 25526892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.